mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |